Indianapolis, INNCT07746947Now EnrollingIRB Ready

Management of Ischemic Stroke Clinical Trial in Indianapolis, IN

Access cutting-edge management of ischemic stroke treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Indiana University

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions…

Expert Care in Indianapolis

Access management of ischemic stroke specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related management of ischemic stroke treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this management of ischemic stroke clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Management of Ischemic Stroke Study in Indianapolis

Investigators are conducting a real world, observational, prospective, multicenter study to better understand treatment for patients with MeVo and distal vessel occlusions in the U.S post publication of recent MeVO trials.

Sponsor: Indiana University

Who Can Participate

Inclusion Criteria

Acute ischemic stroke clinically eligible for immediate EVT
Age ≥18 - 85 years of age
Time from onset (or last-seen-well) to 24 hours
Disabling stroke defined as follows: A. Baseline National Institutes of Health Stroke Scale (NIHSS) score \>5 B. Baseline NIHSS 3-5 with disabling deficit (e.g., hemianopia, aphasia, loss of hand function) as determined and agreed upon by two physicians in context of the patient's life
Confirmed treatable MeVO based on neurovascular non-invasive imaging (CTA or MRA), at one or more of the following locations: M2 or M3 segment, A2 or A3 segment, P1, P2 or P3 segment
Informed consent: Within the first 72 hours after inclusion in the study

Exclusion Criteria

ASPECTS ≤ 5
Any intracranial hemorrhage on initial CT head non contrast
Known pregnancy (local protocol to determine if patient is pregnant at the time of stroke)
Known severe allergy (more than a rash) to contrast media uncontrolled by medications
CT evidence of the following conditions:
Midline shift or herniation
Mass effect with effacement of the ventricles
Acute bilateral strokes
Contraindication to antiplatelet (aspirin, clopidogrel, ticagrelor, cangrelor) or contrast agents
Intracranial tumors other than small meningioma that does not require surgery for one year post randomization.
Known hemorrhagic diathesis, coagulation factor deficiency, or on anticoagulant therapy with an International Normalized Ratio (INR) of \>3.0 or Partial Thromboplastin Time (PTT) \>3 times of normal
Baseline platelet count \<80,000 per microliter (µl)
Life expectancy is less than one year prior to stroke onset14. Participation in another randomized clinical trial that could confound the evaluation of the study outcomes 15\. Any other condition (in the opinion of the site investigator) that precludes an endovascular procedure or poses a significant hazard to the patient if an endovascular procedure was performed

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT07746947) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Management of Ischemic Stroke Treatment Options in Indianapolis, IN

If you're searching for management of ischemic stroke treatment options in Indianapolis, IN, this clinical trial (NCT07746947) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced management of ischemic stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all management of ischemic stroke clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Indianapolis, IN

See all stroke clinical trials recruiting in Indianapolis — not just this study.

Browse Stroke Trials in Indianapolis →

Browse More Trials by Condition

Stroke TrialsHeart Attack TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN